TRMT2A
TRMT2A (tRNA methyltransferase 2A, also known as HTF9C) is an S-adenosyl-L-methionine-dependent RNA methyltransferase that forms 5-methyl-uridine in tRNAs and some mRNAs. It belongs to the RNA M5U methyltransferase family and acts mainly on cytosolic tRNAs. Browse Assay Genie's current range of TRMT2A research reagents below, or read on for the biology behind the target.
TRMT2A is an S-adenosyl-L-methionine-dependent methyltransferase that catalyses the formation of 5-methyl-uridine in tRNAs and some mRNAs. Its main reaction is methylation of uridine at position 54 (m5U54) in cytosolic tRNAs. The enzyme is also able to mediate 5-methyl-uridine formation in a subset of mRNAs, so its activity is not restricted to tRNA. UniProt records the protein in the cytosol.
The TRMT2A protein belongs to the class I-like SAM-binding methyltransferase superfamily and to the RNA M5U methyltransferase family. HGNC places the gene in the groups of 7BS C5-uridine RNA methyltransferases and DNA/RNA methyltransferases, and also lists it among microRNA protein coding host genes. According to the NCBI Gene summary, the encoded protein contains an RNA methyltransferase domain and is orthologous to the mouse Trmt2a gene. Several transcript variants encoding two different isoforms have been described for the TRMT2A gene.
NCBI notes that TRMT2A expression varies during the cell cycle, and that aberrant expression is a possible biomarker in certain breast cancers. The gene has also been called HTF9C, and earlier HGNC names described it as a homologue of the S. cerevisiae tRNA methyltransferase 2. These features make TRMT2A a useful subject for studies of RNA modification, tRNA biology and cell-cycle-linked gene expression.
TRMT2A catalyses m5U54 formation in cytosolic tRNAs, making it a focus for studies of how tRNA methylation is established.
The enzyme can also form 5-methyl-uridine in some mRNAs, extending its relevance to RNA modification beyond tRNA.
TRMT2A expression varies during the cell cycle, which makes it of interest when examining cell-cycle-dependent RNA metabolism.
Aberrant TRMT2A expression has been proposed as a possible biomarker in certain breast cancers.
TRMT2A is an S-adenosyl-L-methionine-dependent methyltransferase that forms 5-methyl-uridine in tRNAs and some mRNAs. Its main activity is methylation of uridine at position 54 (m5U54) in cytosolic tRNAs, and it is found in the cytosol.
TRMT2A is also known as HTF9C and as tRNA (uracil-5-)-methyltransferase homolog A. Earlier names include tRNA methyltransferase 2 homolog A. NCBI reports several transcript variants encoding two different isoforms. Check the datasheet of any product for its validated reactivity.
TRMT2A is orthologous to the mouse Trmt2a gene and contains an RNA methyltransferase domain. NCBI notes that its expression varies during the cell cycle and that aberrant expression is a possible biomarker in certain breast cancers.
Other RNA methyltransferases and RNA-modification enzymes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8IZ69; product specifications from Assay Genie datasheets.